Sperogenix Therapeutics
PrivateLast Round
Series B
Oct 23, 2023
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sperogenix Therapeutics operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in October 2023.
Sperogenix Therapeutics is a pharmaceutical company that develops and commercializes rare disease therapeutics in China.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sperogenix Therapeutics Comparables
Compare Sperogenix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CS Pharmaceuticals | 78% | |
| Hongkong Winhealth Pharma Group | 78% | |
| CANbridge Pharma | 72% |
For institutional investors. Book with your work email.
Sperogenix Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sperogenix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
| Jingxu Venture Capital | Series A |
| Lilly Asia Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 129, 860% of headcount.
- Jul 26, 2026
Monthly visitors grew 695% MoM, from 255 to 2K.
For institutional investors. Book with your work email.
Sperogenix Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sperogenix Therapeutics's valuation, stock price, and market status.
Is Sperogenix Therapeutics a public or private company?
Sperogenix Therapeutics is a private company.
What is the current stock price of Sperogenix Therapeutics?
Sperogenix Therapeutics is a private company, so its shares have no public market price. Caplight tracks Sperogenix Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sperogenix Therapeutics worth (valuation)?
Valuation information for Sperogenix Therapeutics is not publicly available.
Can I buy Sperogenix Therapeutics stock?
Sperogenix Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sperogenix Therapeutics's last funding round?
Sperogenix Therapeutics's most recent funding round was Series B on October 23, 2023.
Who are the main investors in Sperogenix Therapeutics?
Key investors in Sperogenix Therapeutics include Morningside Ventures, Jingxu Venture Capital, Lilly Asia Ventures.
Will Sperogenix Therapeutics IPO soon?
No public IPO plans have been announced for Sperogenix Therapeutics.
How can I track Sperogenix Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Sperogenix Therapeutics's shares on secondary markets.